1. Home
  2. OCUL vs CODI Comparison

OCUL vs CODI Comparison

Compare OCUL & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • CODI
  • Stock Information
  • Founded
  • OCUL 2006
  • CODI 2005
  • Country
  • OCUL United States
  • CODI United States
  • Employees
  • OCUL N/A
  • CODI N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • CODI Home Furnishings
  • Sector
  • OCUL Health Care
  • CODI Consumer Discretionary
  • Exchange
  • OCUL Nasdaq
  • CODI Nasdaq
  • Market Cap
  • OCUL 1.4B
  • CODI 1.6B
  • IPO Year
  • OCUL 2014
  • CODI 2006
  • Fundamental
  • Price
  • OCUL $9.16
  • CODI $22.94
  • Analyst Decision
  • OCUL Strong Buy
  • CODI Buy
  • Analyst Count
  • OCUL 8
  • CODI 2
  • Target Price
  • OCUL $16.50
  • CODI $26.50
  • AVG Volume (30 Days)
  • OCUL 889.3K
  • CODI 195.9K
  • Earning Date
  • OCUL 11-14-2024
  • CODI 10-30-2024
  • Dividend Yield
  • OCUL N/A
  • CODI 4.36%
  • EPS Growth
  • OCUL N/A
  • CODI 38.85
  • EPS
  • OCUL N/A
  • CODI 0.56
  • Revenue
  • OCUL $61,442,000.00
  • CODI $2,216,497,000.00
  • Revenue This Year
  • OCUL $15.49
  • CODI $13.12
  • Revenue Next Year
  • OCUL $13.31
  • CODI $8.93
  • P/E Ratio
  • OCUL N/A
  • CODI $41.25
  • Revenue Growth
  • OCUL 6.45
  • CODI 16.71
  • 52 Week Low
  • OCUL $2.05
  • CODI $19.76
  • 52 Week High
  • OCUL $11.78
  • CODI $25.07
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 34.86
  • CODI 60.98
  • Support Level
  • OCUL $10.46
  • CODI $20.88
  • Resistance Level
  • OCUL $11.12
  • CODI $23.54
  • Average True Range (ATR)
  • OCUL 0.57
  • CODI 0.56
  • MACD
  • OCUL -0.22
  • CODI 0.17
  • Stochastic Oscillator
  • OCUL 0.60
  • CODI 79.80

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: